Glaucoma imaging influenced by the presence of cataracts

Article

The presence of cataracts has been shown to influence OCT image quality.

The presence of cataracts has been shown to influence OCT image quality, according to a study recently published in the Journal of Glaucoma.

A team of researchers, led by Dr Sánchez-Cano of the Miguel Servet University Hospital, Zargoza, Spain, found that the presence of cataracts can affect the quality of the image obtained with a glaucoma imaging device and also that phacoemulsification improved measurements in all cases after cataract removal.

The study group comprised 46 eyes from 46 patients who underwent OCT, confocal laser scanning ophthalmoscopy and a scanning laser polarimetry both pre- and post-phacoemulsification.

It was revealed that all three types of imaging device showed improvement in quality and measurements taken after the patient's cataract had been removed, especially in OCT image quality. Additionally, important differences between pre- and post-op measurements of cup depth and volume parameters were observed.

Recent Videos
Dr Rick Lewis discusses the FLigHT procedure and ViaLase laser at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting
Christiana Dinah speaks about her ASRS presentation, Real-World Treatment Outcomes With Anti-VEGF Therapy in Patients With Retinal Vein Occlusion in the UK
Chase Ludwig, MD, shared an overview of his presentation, which covered real-impact of vitrectomy surgery on the progression of AMD at the annual ASRS meeting in Stockholm, Sweden
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.